Literature DB >> 20093496

A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

Umeko Semba1, Jun Chen, Yoshihiko Ota, Nan Jia, Hidetoshi Arima, Hiroshi Nishiura, Tetsuro Yamamoto.   

Abstract

A monocyte-chemoattracting factor is generated during blood coagulation and during clotting of platelet-rich plasma. This chemotactic factor attracts monocytes as a ligand of the C5a receptor; however, it inhibits C5a-induced neutrophil chemotaxis as an apparent receptor antagonist. The curious dual function of the serum monocyte chemotactic factor resembles that of the cross-linked homodimer of ribosomal protein S19 (RP S19). Indeed, the inactive precursor of the monocyte chemotactic factor was present in plasma, and the precursor molecule and RP S19, as well as the active form and the RP S19 dimer, were indistinguishable in terms of immunological reactivity and molecular size. Coagulation factor XIIIa, plasma transglutaminase, and membrane phosphatidylserine on the activated platelets were required for conversion of the precursor to the active form. In addition, the precursor molecule in plasma could be replaced by wild-type recombinant RP S19 but not by mutant forms of it. These results indicate that a molecule indistinguishable from RP S19 was present in plasma, and that the RP S19-like molecule was converted to the active form by a transglutaminase-catalyzed reaction on a scaffold that included the phosphatidylserine-exposed platelet membrane.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093496      PMCID: PMC2832172          DOI: 10.2353/ajpath.2010.090720

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Molecular complexes in the isolation and characterization of plasma lipoproteins.

Authors:  D G CORNWELL; F A KRUGER
Journal:  J Lipid Res       Date:  1961-04       Impact factor: 5.922

2.  Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell.

Authors:  Marcus Dittrich; Ingvild Birschmann; Julia Pfrang; Sabine Herterich; Albert Smolenski; Ulrich Walter; Thomas Dandekar
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

3.  A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells.

Authors:  K Horino; H Nishiura; T Ohsako; Y Shibuya; T Hiraoka; N Kitamura; T Yamamoto
Journal:  Lab Invest       Date:  1998-05       Impact factor: 5.662

4.  Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.

Authors:  Lei Shi; Shigeyuki Tsurusaki; Noriko Futa; Tamami Sakamoto; Tomoko Matsuda; Norikazu Nishino; Ryuji Kunitomo; Michio Kawasuji; Kazutaka Tokita; Tetsuro Yamamoto
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

Review 5.  Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes.

Authors:  Tetsuro Yamamoto
Journal:  Pathol Int       Date:  2007-01       Impact factor: 2.534

6.  Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity.

Authors:  H Nishiura; S Tanase; Y Sibuya; T Nishimura; T Yamamoto
Journal:  Lab Invest       Date:  1999-08       Impact factor: 5.662

7.  S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a.

Authors:  H Nishiura; Y Shibuya; T Yamamoto
Journal:  Lab Invest       Date:  1998-12       Impact factor: 5.662

8.  Development of C5a receptor antagonists. Differential loss of functional responses.

Authors:  Z D Konteatis; S J Siciliano; G Van Riper; C J Molineaux; S Pandya; P Fischer; H Rosen; R A Mumford; M S Springer
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

9.  Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein.

Authors:  H Nishiura; Y Shibuya; S Matsubara; S Tanase; T Kambara; T Yamamoto
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

10.  S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor.

Authors:  Hiroshi Nishiura; Sumio Tanase; Yoko Shibuya; Noriko Futa; Tamami Sakamoto; Adrian Higginbottom; Peter Monk; Jörg Zwirner; Tetsuro Yamamoto
Journal:  J Cell Biochem       Date:  2005-02-15       Impact factor: 4.429

View more
  5 in total

1.  Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-28       Impact factor: 10.793

2.  RP S19 C-terminal peptide trimer acts as a C5a receptor antagonist.

Authors:  Hiroshi Nishiura; Toru Kawakami; Mutsuki Kawabe; Nahoko Kato-Kogoe; Naoko Yamada; Keiji Nakasho; Koji Yamanegi
Journal:  Biochem Biophys Rep       Date:  2016-05-10

3.  Dual functions of the C5a receptor as a connector for the K562 erythroblast-like cell-THP-1 macrophage-like cell island and as a sensor for the differentiation of the K562 erythroblast-like cell during haemin-induced erythropoiesis.

Authors:  Hiroshi Nishiura; Rui Zhao; Tetsuro Yamamoto
Journal:  Clin Dev Immunol       Date:  2012-12-30

Review 4.  Immune Aging and How It Works for Inflammation and Fibrosis.

Authors:  Hiroshi Nishiura; Mai Imasaka; Koji Yamanegi; Jiro Fujimoto; Masaki Ohmuraya
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

Review 5.  Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.

Authors:  Fahad S M Alshehri; Claire S Whyte; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.